The neuraminidase (NA) inhibitors (NAIs), zanamivir and oseltamivir, are effective antiviral drugs for the treatment and prevention of influenza A and B infections [1] . Emergence of resistance under oseltamivir treatment occurs at low frequency in adults but can be more frequent in children [2] . Until 2007, <1% of viral isolates screened for susceptibility to NAIs in global surveillance studies were found to be naturally resistant to oseltamivir [3, 4] . However, during the 2007-2008 influenza season, A(H1N1) viruses naturally resistant to oseltamivir due to a His to Tyr substitution at position 275 of the NA gene (in N1 numbering) emerged and spread in the human population [5] [6] [7] . Although initial emergence may have been due to oseltamivir usage, their subsequent spread was unrelated to selective drug pressure, as there was no correlation between the prevalence of resistant viruses and oseltamivir usage [8] . In contrast to former seasonal H1N1 viruses, oseltamivirresistant H1N1 viruses from the 2007-2008 season (08-H1N1 viruses) show unimpaired fitness in cell culture [9, 10] . In a previous study, we found that the NA of 08-H1N1 viruses had an increased affinity for sialic acids as compared with H1N1 viruses from the previous decade (prev-H1N1 viruses), and we suggested that an optimal balance between the functions of the haemagglutinin (HA) and the NA of 08-H1N1 viruses might have been restored by the H275Y mutation on the NA [9] . In this study, we further investigated the Introduction molecular bases for the particular enzymatic properties of the NA of 08-H1N1 viruses.
Methods
The sequences encoding the NA and the sequences corresponding to the HA and NA segments were amplified from viral RNA by reverse transcriptase (RT)-PCR, and cloned into the pCI vector (Invitrogen, Carlsbad, CA, USA) or into the pPR7 vector, respectively, as described previously [11] . Two independent pCI-N1 clones were selected for each virus included in the study. Site-directed mutagenesis was performed using the QuickChange ® Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA).
Subconfluent monolayers of 293T cells were transfected with pCI-NA plasmids by using the FuGENE 6 transfection reagent (Roche, Basel, Switzerland). Surface cell expression of NA was assessed by FACSCAN (FACSCalibur; Becton Dickinson, Franklin Lakes, NJ, USA) using a polyclonal rabbit serum raised against A/New Caledonia/20/99(H1N1) virus produced by the NIC Northern-France [12] . At 48 h post-transfection, NA enzymatic activity was measured on cell extracts using the fluorogenic substrate 2′-(4-methylumbelliferyl)-α-d-N-acetylneuraminic acid (MUNANA; Sigma, St Louis, MO, USA), and the fluorescence of the released 4-methylumbelliferone was measured using a Xenius spectrofluorometer (SAFAS-Monaco, Monaco, Monaco), as previously described [12] . The K m , V m and K i parameters (defined below) were calculated by fitting the data to the appropriate Michaelis-Menten equations using KaleidaGraph software (Synergy Software, Essex Junction, VT, USA). The rate of sialic acid hydrolysis by the NA is predicted by Equation 1:
where V 0 is the rate of substrate hydrolysis in the absence of inhibitor, V m the maximal initial rate (that is, as measured when [S]>>K m ), [S] the substrate concentration and K m is the Michaelis-Menten constant for the hydrolysis of sialic acid by influenza NA. The reduction of NA activity in the presence of a competitive drug is predicted by Equation 2:
where V i is the rate of substrate hydrolysis in the presence of inhibitor, [I] is the concentration of inhibitor and K i is the dissociation constant for the enzyme/ inhibitor complex. For reverse genetics, cocultures of 293T and MadinDarby canine kidney (MDCK) cells were transfected with the pPR7-HA and pPR7-NA plasmids, together with reverse genetics plasmids derived from the A/ Wilson Smith Neurotropic/33 (A/WSN/33) virus as described previously [11] . Plaque assays were performed on MDCK-SIAT1 cells. Plaques were visualized after 2 or 3 days of incubation at 37°C for determination of the mean plaque diameter using equipment (Carl Zeiss, Oberkochen, Germany) with a magnifying screen and lateral sliding measurement device.
Results
Three of the residues that differ between the NAs of 08-H1N1 and prev-H1N1 viruses [9] , residues 222, 249 and 344 in N1 numbering, are located close to the catalytic site ( Figure 1 Substitutions were introduced at residues 222 (Q/R), 249 (K/G), 344 (N/D) and/or 275 (H/Y) using sitedirected mutagenesis. The enzymatic properties of the wild-type and mutated NAs were characterized by performing enzymatic kinetics with a fluorogenic substrate on cell extracts prepared from 293T cells transiently expressing the NA, as described previously [12] .
The enzymatic parameters measured on the recombinant wild-type NAs (Table 1) were in agreement with our previous measurements using whole viruses [9] . The affinity towards the MUNANA substrate (K m ) was little affected by substitutions at residues 222 and 249, whereas the nature of residue 344 had a major effect on the K m ( Table 1 ). The N344D substitution in the NA of 08-H1N1 viruses significantly increased the K m (from 8.9 µM to 33 µM; P<0.001). Reciprocally, the D344N substitution in the NA of prev-H1N1 viruses led to a K m that was significantly decreased (7.5 µM as compared with 22 µM for the wild-type; P<0.001), and was close to the K m measured for the NA of wild-type 08-H1N1 viruses. As expected from previous studies [12, 13] , the H275Y substitution induced a twofold increase of the K m (P<0.01 to P<0.001), whatever the genetic background (08-H1N1 or prev-H1N1 viruses) and whether or not additional substitutions at residues 222, 249 or 344 were present. The Q222R substitution in the NA of 08-H1N1 viruses was found to significantly reduce the V m 2-3-fold (Table 1) , whereas the reciprocal R222Q substitution on GenBank accession number CY043395) and the sequences of the corresponding domain of the N2 (residues 141-414) of A/Tokyo/3/67 (TKY67; GenBank accession number K01393) were aligned using the CLC software (CLC Bio, Aarhus, Denmark). Amino acid positions corresponding to the N1 and N2 numberings are indicated above and below the alignment, respectively. Conserved residues of the active site are highlighted in dark orange (catalytic residues) or in light orange (framework residues) [22] . The H275 residue (N1 numbering) is highlighted in green. The residues that are close to the catalytic site and that differ between the N1 of 08-H1N1 viruses (represented by BRB07) and prev-H1N1 viruses (represented by SI06) are highlighted in blue. Residue 234 [14] , is highlighted in light blue.
the NA of prev-H1N1 viruses had no effect in agreement with recent data from Bloom et al. [14] .
In agreement with the observed resistance to oseltamivir and susceptibility to zanamivir of H275Y mutant H1N1 viruses [12, 13, 15] , the H275Y substitution induced an approximately 600-fold increase of the K i for oseltamivir of all recombinant NAs, whereas the K i for zanamivir remained low ( Table 1 ). The N344D substitution in the NA of 08-H1N1 viruses, in the presence as well as in the absence of the H275Y substitution, resulted in a significant 2-3-fold increase of the K i for both oseltamivir and zanamivir (Table 1) . Reciprocally, the D344N substitution in the NA of prev-H1N1 decreased the K i for both inhibitors.
A systematic analysis of N1 sequences available in public databases revealed that a significant propor- Table 2 ). These NAs notably differ by a V234M change. Recent findings [14] showed a slight reduction in the level of expression when the V234M mutation was introduced in the NA of A/New Caledonia/20/99, which was somewhat more pronounced in the presence of the H275Y mutation. The lack of an effect seen here may be related to other differences in . This allowed us to study the effect of the H275Y mutation as both NAs differed only by H275Y and G354D substitutions, the latter having been shown to have no effect on the enzymatic properties of the NA [9] . Reassortant viruses expressing the HA and the wild-type or H275Y-mutated NA of A/Paris/0650/2004 in an A/ 
Discussion
Taken together, our data establish that a single D to N substitution at residue 344 accounts for the increased affinity for the sialic acids and for NAIs of the NA of the 08-H1N1 viruses compared to the prev-H1N1 viruses. The effect of the D344N substitution within the active site of the enzyme was modelled using the three-dimensional structure of the N1 of the 1918 virus complexed with zanamivir [16] as a template. According to our model, replacement of the acidic D by the bipolar N residue at position 344 resulted in a weaker hydrogen bond with the catalytic residue R293, and consequently a reorientation and an increased binding of the R293 to the carboxyl group of zanamivir ( Figure  3 ). This carboxyl group, which plays an essential part in electrostatic interactions with residues of the NA catalytic site [17] is shared by sialic acids, oseltamivir and zanamivir. This model is thus supported by the finding in our enzymatic assays that the D344N substitution induced similar changes on the K m and the K i for both inhibitors. Similar hypotheses about the consequences of the D344N substitution were formulated by Collins et al. [18] based on the crystal structure of the N1 of H5N1 viruses complexed with oseltamivir. In addition, the R222Q substitution in the context of 08-H1N1 viruses seems to have resulted in increased NA velocity. Furthermore, as recently shown by Bloom et al. [14] , the V234M change in conjunction with the R222Q substitution accounts for increased levels of NA expression, especially in the presence of the H275Y mutation. The D344N substitution in the NA of recent H1N1 viruses, possibly in conjunction with the R222Q and V234M substitutions, may thus have resulted in an alteration of the HA/NA balance and thus promoted the emergence and spread of oseltamivir-resistant viruses. To what extent differences in enzymatic characteristics of the NA assessed in vitro using the MUNANA substrate are reproduced in vivo with the natural substrate is not known. However, the above hypothesis is supported by our data on 6:2 reassortant viruses, which show that the H275Y mutation is deleterious if the surface glycoproteins derive from a 2004 isolate, but not from isolates of the 2007-2008 season. However, in these in vitro experiments, as seen by others [10] , the effect was small, likely due to the fact that although viral replication on MDCK-SIAT1 cells is dependent on NA activity [19] , they only partially reproduce conditions of replication in the human respiratory epithelium. H1N1 viruses naturally resistant to oseltamivir did not emerge in 2000-2002, although most of them showed an N at position 344 but neither the 222Q nor 234M. However, 08-H1N1 oseltamivir-resistant viruses emerged independently among viruses of clade 2B and clade 2C, which shared the D344N, R222Q and V234M substitutions, but resistant viruses of clade 2B were the only ones to spread worldwide. This suggests that other genetic changes, for instance in the HA or the polymerase complex genes, that distinguish clade 2B and 2C viruses were probably involved. Following several independent events of emergence, resistant H1N1 viruses might have undergone local evolution and reassortments until a single lineage became predominant, possibly through genomic hitchhiking, as suggested recently for H3N2 viruses resistant to adamantanes [20] .
Widespread oseltamivir resistance is of major concern especially following the emergence of the pandemic H1N1 2009 viruses in the population. So far, resistant pandemic H1N1 viruses have been detected on rare occasions, mainly in the context of prophylactic drug usage or in immunodeficient patients [21] , and there is currently no evidence that they can spread. The NA of the pandemic 2009 virus shows an N residue both at positions 344 and 222. Our finding that a single mutation in the N1 may significantly alter the enzymatic properties of the N1, which may in turn favour the emergence of natural resistance to oseltamivir, calls for additional studies to identify determinants of viral fitness in the presence of the mutations conferring resistance to NAIs, and for a close surveillance of such determinants. [16] . The catalytic residues R293, R368 and R118 are represented in blue. The hydrogen bond between residue R293 and the carboxyl group of Z (coloured in red) is represented by a black dotted line. The hydrogen bond between residue R293 and residue (A) N344 or (B) D344 is represented by a red dotted line, and the corresponding distance is indicated. This interaction is favoured in the presence of a D344, thus pulling R293 away from the carboxyl group of Z. Shown in grey is a calcium ion.
form of the ethyl ester prodrug oseltamivir phosphate, was kindly provided by Roche.
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